Switch to:
More From Other Websites
Acceleron Pharma Inc Conference Call to Review Data Presented at American Society of Hematology... Dec 05 2016
Acceleron and Celgene Announce Preliminary Results from an Investigator Initiated Phase 2 Study of... Dec 05 2016
2:35 pm Celgene: Acetylon Pharma announces it will be acquired by Celgene; terms not disclosed Dec 04 2016
Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment Dec 04 2016
Acceleron and Celgene Announce Updated Results from Ongoing Phase 2 Studies of Luspatercept in... Dec 04 2016
Celgene buys part of Boston cancer drug firm Dec 04 2016
Celgene Corporation, Dana-Farber Cancer Institute and University of Arkansas for Medical Sciences... Dec 03 2016
Bluebird Rockets On Myeloma Drug; Celgene Gets Boost Dec 01 2016
Here's Why Bluebird Bio (BLUE) is Rallying Today Dec 01 2016
Bluebird Bio Flies; Blood Cancer Drug Impresses In Small Trial Dec 01 2016
Celgene Invests More In Data Analytics Software (CELG) Dec 01 2016
Here’s What’s So Important About The bluebird bio Inc (BLUE) Data Dec 01 2016
Bluebird bio stock gains on impressive early cancer trial results Dec 01 2016
Bluebird Bio, Celgene Multiple Myeloma Therapy Strong In 9-Patient Study Dec 01 2016
Is Celgene Corporation (CELG) Worthy of Your Portfolio? Dec 01 2016
Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop Nov 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK